Checkpoint Therapeutics Inc

NASDAQ:CKPT   4:00:00 PM EDT
2.05
+0.01 (+0.49%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)48.23M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.02 Million
Adjusted EPS-$0.27
See more estimates
10-Day MA$2.00
50-Day MA$1.97
200-Day MA$2.18
See more pivots

Checkpoint Therapeutics Inc Stock, NASDAQ:CKPT

95 Sawyer Road, Suite 110, Waltham, Massachusetts 02453
United States of America
Phone: +1.781.652.4500
Number of Employees: 23

Description

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.